Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure
Sonali M. Smith(University of Chicago), Mehdi Hamadani(Medical College of Wisconsin), Mitchell S. Cairo(New York Medical College), Javier Bolaños‐Meade(Johns Hopkins University), Siddhartha Ganguly(University of Kansas Medical Center), Álvaro Urbano-Ispizúa(University of St.Gallen), Praveen Ramakrishnan Geethakumari(Southwestern Medical Center), James Godfrey(City of Hope), Vaibhav Agrawal(City Of Hope National Medical Center), Mohamed A. Kharfan‐Dabaja(Jacksonville College), Edward A. Copelan(Levine Cancer Institute), Vaishalee P. Kenkre(University of Wisconsin–Madison), Ravi Vij(Washington University in St. Louis), Saurabh Chhabra(Medical College of Wisconsin), Harry C. Schouten, Sairah Ahmed(The University of Texas MD Anderson Cancer Center), Asad Bashey, Hillard M. Lazarus(University Hospitals of Cleveland), Parastoo B. Dahi(Memorial Sloan Kettering Cancer Center), Alessandro Digilio, Alberto Mussetti(Duran i Reynals Hospital), Andreas K. Klein(Tufts Medical Center), Taiga Nishihori(Moffitt Cancer Center), Matthew Mei(City of Hope), Abraham S. Kanate(HonorHealth), Veronika Bachanová(University of Minnesota), Mark Hertzberg(The University of Sydney), Ulrike Bacher(Hattiesburg Clinic), David J. Inwards(Mayo Clinic), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Julie M. Vose(University of Nebraska Medical Center), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Nirav N. Shah(Medical College of Wisconsin), Bipin N. Savani(Vanderbilt University Medical Center), Umar Farooq(Wake Forest University), Andy Chen(Stanford University), Reem Karmali(Northwestern University), Leona Holmberg(University of Washington), Kwang Woo Ahn(Medical College of Wisconsin)
Cited by 76
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k